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ORIGINAL ARTICLE
Emotional responses to a negative emotion induction procedure 
in Borderline Personality Disorder
Albert Feliu-Solera,*, Juan Carlos Pascuala, Joaquim Solera, Víctor Péreza,  
Antonio Armariob, Javier Carrascob, Antoni Sanzb, Francisco Villamarínb, Xavier Borràsb
a Universitat Autònoma de Barcelona, IIB-SANT PAU and Centro de Investigación Biomédica en Red de Salud Mental, 
CIBERSAM, Spain 
b Universitat Autònoma de Barcelona and Instituto de Salud Carlos III, Spain
Received June 18, 2012; accepted October 29, 2012
*Corresponding author at: Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, St. Antoni M.ª Claret, 167,  
08025 Barcelona, Spain.  
 E-mail address: afelius@santpau.cat (A. Feliu-Soler).
Abstract The aim of this study was to determine if patients with Borderline Personality 
Disorder (BPD) present higher emotional response than healthy controls in a laboratory setting. 
Fifty participants (35 patients with BPD and 15 healthy controls) underwent a negative emotion 
induction procedure (presentation of standardized unpleasant images). Subjective emotional 
responses were assessed by means of self-reported questionnaires while biological reactivity 
during the procedure was measured through levels of salivary cortisol (sCORT) and alpha-
amylase (sAA). Patients with BPD exhibited significant lower cortisol levels and higher sAA levels 
compared to controls. Self-reported emotional reactivity did not give rise to differences 
between groups but participants with BPD did present higher levels of negative emotional 
intensity at baseline and during the entire procedure. The findings do not give support to the 
emotional hyperreactivity hypothesis in BPD. However, BPD patients presented heightened 
negative mood intensity at baseline, which should be considered a hallmark of the disorder. 
Further studies using more BPD-specific emotion inductions are needed to confirm the trends 
observed in this study.
© 2012 Asociación Española de Psicología Conductual. Published by Elsevier España, S.L.  
All rights reserved.
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Emotional dysregulation is considered a core characteristic 
of Borderline Personality Disorder (BPD) and it is commonly 
reported by patients with BPD (Leichsenring, Leibing, 
Kruse, New, & Leweke, 2011; Rosenthal et al., 2008). Since 
many of the impulsive behaviors that are typically over-
expressed in patients with BPD (i.e. self-mutilation, drug 
abuse, binge eating, suicide attempts) can be triggered by 
emotional dysregulation (Lynch, Chapman, Rosenthal, Kuo, 
& Linehan, 2006), it appears to play a crucial role in the 
severity of the disorder.
According to the biosocial model of Dialectical Behavior 
Therapy (Linehan, 1993), emotional dysregulation involves 
overall elevated negative emotional arousal, heightened 
emotional reactivity to emotional stimuli, and delayed 
recovery to emotional baseline following a negative 
emotional cue (Koenigsberg et al., 2009; Kuo & Linehan, 
2009; Linehan, 1993). Many studies have found that BPD 
patients present heightened negative emotional intensity at 
baseline but there are conflicting results regarding 
emotional reactivity (especially on physiological variables; 
Rosenthal et al., 2008). Thus, some studies (Ebner-Priemer 
et al., 2005; Limberg, Barnow, Freyberger, & Hamm, 2011) 
have reported emotional hyperreactivity in BPD patients vs. 
healthy controls (HC), whereas other authors (Herpertz, 
Kunert, Schwenger, & Sass, 1999; Herpertz et al., 2000) 
have observed hyporreactivity (lower skin conductance 
response) in BPD patients. Similar results were also reported 
by Nater et al., (2010), who evaluated a sample of BPD 
patients with a standardized psychosocial stress protocol 
(Trier Social Stress Test); these authors found less reactivity 
of the hypothalamus-pituitary-adrenal axis (HPAA) and 
Sympathetic Nervous System (SNS) compared to a HC group. 
In addition to these conflicting results, other authors (Kuo & 
Linehan, 2009) have found no significant differences in 
reactivity between BPD and HC groups.
Given these conflicting results in the literature, we 
decided to perform a study to determine whether or not 
BPD patients exhibit greater emotional reactivity, using a 
standardized negative emotional induction to provoke 
changes in self-reported emotional variables and salivary 
stress markers. Additionally, higher scores of negative 
emotions in the BPD group are expected to be found.
Method
Participants
Forty-two outpatients were recruited from the BPD Unit of 
the Hospital de la Santa Creu i Sant Pau; of these, 7 failed to 
meet the exclusion criteria and therefore a total of 
35 participants were included. The healthy control (HC) 
group included 15 volunteers matched by gender and age to 
the BPD group (Table 1). All HCs were recruited from 
employees at our hospital and agreed to voluntarily 
participate in the study. Since 7 participants of the BPD 
group and 2 from the HC group did not salivate enough, the 
final sample for biochemical analyses was reduced to 28 and 
13 respectively.
BPD diagnosis was determined by psychiatric evaluation 
and two semi-structured diagnostic interviews: the SCID-II 
(Structured Clinical Interview for DSM-IV axis II disorders; 
Spanish version; Gómez-Beneyto et al., 1994) and DIB-R 
(Revised Diagnostic Interview for Borderline, Spanish 
validation; Barrachina et al., 2004). Both SCID-II and DIB-R 
showed good psychometric properties with an internal 
reliability of .89 for DIB-R (Barrachina et al., 2004) and an 
adequate Cronbach’s alpha ranging between .71 and .94 for 
SCID-II (Maffei et al., 1997). Inclusion criteria for BPD 
patients were as follows: age between 18 and 45 years; and 
a score ≥4 on the Clinical Global Impression Scale for 
Borderline Personality Disorder (CGI-BPD; Pérez et al., 
2007). All BPD patients were receiving pharmacological 
treatment at the time of inclusion in the study and had to 
Resumen El presente estudio pretende determinar si existe o no una mayor reactividad emo-
cional en el Trastorno Límite de la Personalidad (TLP) en un contexto de laboratorio. Se realizó 
una inducción emocional negativa (presentación de imágenes estandarizadas con contenido 
negativo) a cincuenta participantes (35 pacientes con TLP y 15 controles sanos). Para evaluar la 
respuesta emocional subjetiva se utilizaron cuestionarios auto-informados; los niveles de corti-
sol (sCORT) y alfa-amilasa (sAA) salivares se utilizaron para medir la reactividad biológica al 
procedimiento. En el grupo de TLP, se observaron niveles de sCORT más bajos y niveles de sAA 
más elevados en comparación al grupo control. No se observaron diferencias significativas en 
relación a la reactividad emocional auto-informada, pero los pacientes con TLP reportaron may-
or intensidad de emociones negativas a nivel basal así como también durante todo el proced-
imiento. Los resultados no apoyan la hipótesis de hiperreactividad emocional en el TLP. Sin 
embargo, los pacientes con TLP presentaron mayor intensidad de emociones negativas a nivel 
basal, característica que debería ser considerada como esencial en el trastorno. Futuros estu-
dios deberán incorporar otros paradigmas de inducción emocional más específicos para TLP con 
el fin de confirmar las tendencias observadas en el presente estudio.
© 2012 Asociación Española de Psicología Conductual. Publicado por Elsevier España, S.L.  
Todos los derechos reservados.
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have maintained their usual medications and dose levels for 
at least two months prior to the study. Exclusion criteria for 
BPD participants were as follows: a) comorbidity with 
schizophrenia, drug induced psychosis, organic brain 
syndrome, bipolar disorder, mental retardation, current 
major depressive episode, post-traumatic stress disorder, or 
current substance or alcohol abuse or dependence; b) major 
medical illness according to medical history and physical 
examination; c) current structured psychotherapy; or d) 
participation in any similar study or knowledge of the study’s 
purpose. HCs were clinically interviewed to rule out the 
presence of axis I or II pathology and answered the McLean 
Screening Instrument for Borderline Personality Disorder 
(MSI-BPD; Zanarini et al., 2003), which specifically assess 
BPD symptomatology. None of the healthy controls reported 
previous axis I or axis II disorder (including BPD), nor any 
substance dependence. Like BPD participants, the HCs had 
no previous experience in any similar study, were unaware 
of the purpose and procedure of the study, and had no 
involvement in its development. All participants voluntarily 
signed the written consent form after receiving a summary 
of the study. The Clinical Research Ethics Committee of the 
Hospital de la Santa Creu i Sant Pau approved the study 
design, which was carried out in accordance with the 
Helsinki Declaration.
Instruments
Clinical scales and self-reported measures of mood:
•  The Hamilton Rating Scale for Depression (HRSD; Hamilton, 
1960) is a 5-point scale (ranging from 0 for “absent” to 4 for 
“incapacitating symptoms”) with 17 items for assessing 
depressive symptoms. This scale shows an adequate 
reliability as most of the studies indicate Cronbach’s alphas 
>.70 (Bagby, Ryder, Schuller, & Marshall, 2004).
•  The Brief Psychiatric Rating Scale (BPRS; Overall & 
Gorham, 1988) is a 7-point scale (from 1: “not present” to 
7: “extremely severe”) with 18 items used to measure 
psychopathology with high reliability (Cronbach’s α = .80; 
Nicholson, Chapman, & Neufeld, 1995).
•  Self-Assessment-Manikin (SAM; Lang, 1980), a non-verbal 
pictorial affective rating system initially designed to assess 
psychological responses to visual material with emotional 
content (i.e. IAPS). It uses graphic figures to depict values 
along the dimensions of Activation (arousal), Valence 
(pleasure) and Dominance (perceived control). Each 
dimension has a 9-point rating scale ranging from 1 (the 
lowest rating) to 9 (the highest rating). SAM has a 
satisfactory internal reliability with Cronbach’s alphas 
ranging between .63 and .98 (Backs, da Silva, & Han, 
2005).
•  Profile of Mood States (POMS; McNair, Lorr, & Droppleman, 
1971), a 5-point scale (from 0: “not at all” to 4:”extremely”) 
of 65 items created to assess the following six affective 
mood states: Anger, Depression, Tension, Fatigue, Vigor, 
and Friendliness. The total mood disturbance score (TMDS) 
is obtained from scores of the other subscales. The POMS 
presents an adequate reliability for all factors with 
Cronbach’s alphas ranging between .63 and .96 (McNair et 
al., 1971).
•  Positive and Negative Affect Schedule (PANAS; Watson, 
Clark, & Tellegen, 1988), a questionnaire used to assess 
positive and negative emotions. The PANAS consists of 
20 words (10 positive, 10 negative) that describe emotions, 
which are rated from 1 (“very slightly or not at all”) to 5 
Table 1 Summary of demographics and clinical variables.
 Borderline  Healthy p 
 Personality  Controls 
 Disorder (n = 35)  (n = 15) 
Gender (% females) 91.43 86.67 ns
Age, mean (SD) 30.20 (7.21) 30.60 (5.72) ns
Mean years of schooling (SD) 11.17 (2.41) 13.73 (2.09) .001
Marital status (% single) 68.57 53.33 ns
BMI, mean (SD) 24.47 (5.67) 22.86 (3.45) ns
Menstrual period (% in luteal phase) 53.12 46.15 ns
Oral contraceptive treatment (%) 31.25 38.46 ns
PSS score, mean (SD) 26.80 (6.94) 9.67 (4.34) < .001
DIB-R score, mean (SD) 7.52 (1.25) - -
HRS score, mean (SD) 17.69 (3.76) - -
BPRS score, mean (SD) 13.57 (2.76) - -
Pharmacological treatment (%)   
Antidepressant 71.43 - -
Benzodiazepine 51.43 - -
Stabilizer 60 - -
Antipsychotic 62.86 - -
BMI, Body Mass Index; BPRS, Brief Psychiatric Rating Scale; DIB-R, Diagnostic Interview for Borderlines-Revised; HDRS, Hamilton 
Depression Rating Scale; ns, not significant; PSS, Perceived Stress Scale; SD, standard deviation.
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(“very much”) on a Likert scale. Respondents are asked to 
rate how they feel at that moment. Alpha coefficients of 
the scale are excellent (between .87 and .91; Sandín et 
al., 1999).
•  Perceived Stress Scale (PSS-10; Cohen & Williamson, 1988), 
a 10-item scale that uses a Likert rating (from 0: “never” 
to 4: “very often”) to assess participants’ perceived stress 
levels during the month prior to the study. The PSS-10 
shows a good internal consistency with a Cronbach’s 
alpha= .82 (Remor, 2006).
Biochemical measures:
•  Salivary cortisol (sCORT) is a marker of HPAA activation 
and is used to measure the free fraction (i.e. the 
bioavailable fraction) of blood cortisol. Alterations in 
cortisol levels have been associated with negative effects 
of stress on cognitive processes (Portella, Harmer, Flint, 
Cowen, & Goodwin, 2005). Salivary alpha-amylase (sAA) is 
a digestive enzyme used as an indirect indicator of SNS 
activity (Granger, Kivlighan, el-Sheikh, Gordis, & Stroud, 
2007).
The Salimetrics Oral Swabs (Salimetrics®) was used to 
collect saliva samples. The validity of method for concurrent 
assessment of sCORT and sAA has been previously 
demonstrated (Gröschl, 2008). Following the manufacturer’s 
recommendations, participants placed the swab under the 
tongue for two and a half minutes. Unstimulated absorption 
was used because sal iva induction can alter sAA 
concentration. Saliva samples were frozen at −20 ºC until 
laboratory analysis. Levels of sCORT were analyzed with a 
commercial enzyme-linked immunosorbent assay (ELISA), 
with intra-assay coefficients of variation less than 4% and 
inter-assay coefficient no higher than 6.50% (Salimetrics®). 
Levels of sAA were determined by an ELISA that uses a 
substrate that changes color in response to amylase activity; 
intra-assay coefficients of variation were less than 8% with 
inter-assay coefficients no higher than 6% (Salimetrics®). 
Values are expressed in μg/dL for sCORT and units of enzyme 
activity per millilitre for sAA.
Procedure
The laboratory sessions were conducted from January 2009 
to January 2010 and took place in a hospital room 
conditioned for this purpose, with consistent temperature 
and lighting for all sessions. The sessions were conducted 
between 3 p.m. and 6 p.m. to minimize the effects of 
circadian rhythm and time of day on physiological variables. 
To limit possible confounding variables, the following 
instructions were given for the day of the experiment: wake 
up before 8 a.m.; not brush their teeth after dinner (to 
avoid gingival bleeding); not take any medications or 
caffeine on the day of the study; not smoke, eat or drink 
anything except water in the hour prior to starting the study. 
Participants were also instructed not to perform strenuous 
physical exercise or consume alcohol or illegal drugs in the 
24 hours preceding the study (Granger et al., 2007; Kudielka, 
Buske-Kirschbaum, Hellhammer, & Kirschbaum, 2004).
We collected and recorded the following variables that 
may have an effect on sCORT and sAA levels (Hellhammer, 
Wüst, & Kudielka, 2009; Kudielka et al., 2004): gender; 
menstrual phase; use of oral contraceptives, beta-blockers, 
glucocorticoids and hormones; prescribed and non-
prescribed drug use in the last 24 hours; alcohol use in the 
previous 24 hours; smoking in the last 2 hours; caffeine 
consumption in the last hour; intense physical exercise in 
the last 24 hours; time since last meal; stressful events and 
awakening hour on the day of the study.
For emotion induction, participants were individually 
shown 24 pictures taken from the International Affective 
Picture System (IAPS) (Lang, Ohman, & Vaitl, 1988). Images 
were chosen for negative Valence, high Activation and low 
Dominance in SAM scale scores, attributes deemed 
appropriate to induce a significant plasmatic cortisol 
response, as previously described by Codispoti, Gerra et al., 
(2003) –i.e. images from the IAPS have been widely used in 
psychophysiological (Herpertz et al., 1999, 2000) and 
neuroimaging research with BPD patients (Koenigsberg et 
al., 2009) and have been shown capable of inducing changes 
also in sAA levels (van Stegeren, Wolf, & Kindt, 2008). The 
17-inch monitor was located at a distance of 1 meter from 
the participants, who were seated in a comfortable chair. All 
participants rinsed out their mouths prior to starting the 
procedure to reduce possible contaminants in the saliva 
samples.
The procedure lasted 45 minutes and was divided into 3 
separate phases (Fig. 1). The baseline phase (15 min) was 
designed to allow participants to adapt to the setting. During 
this time, instructions were given on how to self-collect the 
saliva and participants completed the computerized 
questionnaires which were used to gather sociodemographic 
data and the self-report questionnaires (POMS-pre, PANAS-
pre). At the end of this phase, participants completed the 
self-reported affective rating scale (SAM baseline) while 
the initial saliva sample (s1) was collected. In the second 
phase (emotional induction), participants viewed the 24 IAPS 
images (30 sec per picture for viewing, with a 3-sec recess 
between pictures). Participants were told to view each 
picture for a full 30 seconds. During this second phase, 
participants completed the self-report affective scales and 
collected two saliva samples: first after viewing the first 
12 images (SAM Induction1, s2), and again after viewing the 
final 12 images (SAM Induction2, POMS-post, PANAS-post, 
s3). Because sAA and sCORT have different latencies of 
response (Dickerson & Kemeny, 2004; van Stegeren et al., 
2008), two saliva samples were taken during this second 
phase. The last phase (15 min) began after completion of 
emotional induction. During this time, participants finished 
answering the questionnaires and final emotional and 
biological measures were taken (SAM Post-induction, s4).
Data analyses
SPSS v.18.0 (SPSS Inc., Chicago, Illinois) was used to perform 
the statistical analysis. All hypotheses were tested with a 
two-tailed significance level of .05. Sociodemographic 
variables were compared using the chi-square test for 
categorical variables and the Student’s t-test for continuous 
variables. PSS scores were compared by means of a t-test 
analysis.
Hierarchical Linear Modelling (HLM) was used to 
investigate group (BPD vs. control), time (phase), and 
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interaction effects for SAM and biological variables 
(corrected df reported). We determined the appropriate 
covariance structure using Akaike’s and Schwarz’s 
information criteria. We used the restricted maximum 
likelihood method, while the distribution for residuals 
was tested using a Kolmogorov-Smirnov test. For all 
analyses, participants were only included if they had a 
baseline measure and at least one induction or post-
induction measure. For scales with 2 measurements (i.e. 
baseline and the post-induction phases: POMS and PANAS), 
repeated measures MANOVA were performed. To assess 
between-group differences in recovery, the deltas 
between post-induction and induction1 phases for SAM 
variables were calculated by subtracting the post-
induction values from Induction2, and a MANOVA analysis 
was performed. Depressive symptomatology on biological 
response, correlation analyses within the BPD group 
between HRDS scores and sCORT and sAA levels were 
performed.
Results
Patient demographics and clinical characteristics
There were no significant differences between groups 
regarding gender, age and marital status. However, 
significant statistical differences were observed in years of 
schooling and PSS scores (see Table 1).
Biological variables
Emotion induction failed to induce an increase in cortisol 
levels in either group. Nevertheless, significant main effect 
group x time differences in HLM analysis were found for 
sCORT (F(3,58.40) = 2.90; p = .040). Group differences in cortisol 
levels showed a tendency for significance (F(1,37.36) = 3.86; 
p = .057), with lower cortisol levels in the BPD group. 
Univariate analysis revealed significant differences between 
groups in sCORT at baseline (p = .015) (see Fig. 2 for 
details). 
Significant between-group differences were found for sAA 
levels (F(1,35.83) = 4.54; p = .040), with higher levels of amylase 
activity in the BPD group but without any group x time 
effects (p = .149). Univariate analyses for sAA revealed 
significant differences in the Induction1 and Induction2 
phases (p = .024 and p = .048, respectively) but not at 
baseline (Fig. 2). A significant time effect was also found 
(F(3,36.40) = 4.63; p = .008). No significant effect emerged 
from correlation analyses of HRDS scores and biological 
variables (p> .108).
Self-reported variables
At baseline, all PANAS and POMS subscales showed 
significantly higher scores in the BPD group vs. HC (p< .001). 
Figure 1 Schematic description of the procedure. PANAS, Positive and Negative Affect Schedule; POMS, Profile of Mood States; 
SAM, Self-Assessment-Manikin.
15 min 6:30 min 6:30 min
Pre-induction Emotional induction
POMS-pre
PANAS-pre
15 min
Post-induction
s1
SAM Basal
s2
SAM Induction1
s3
SAM Induction2
POMS-post
PANAS-post
s4
SAM
post-induction
Baseline Induction1
*
Control
BPD
Induction2 Post-induction
0.25
0.20
0.15
0.10
0.05
0.00
Baseline Induction1
*
Control
BPD
Induction2 Post-induction
60
50
40
30
20
10
0
sA
A 
(U
/m
L)
*
*p < .05
Figure 2 Mean and SEM values for salivary cortisol (sCORT) 
and alpha-amylase (sAA) during the procedure. BPD, Borderline 
Personality Disorder.
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The MANOVA repeated measures analysis showed significant 
between-group differences for POMS and PANAS variables 
(F(1,9) = 8.02; p< .001), with the BPD group tending to show a 
more negative mood. A time effect was also observed in the 
MANOVA, indicating that emotion induction was effective 
(F(1,9) = 2.97; p = .009). However, no group x time effect was 
observed (F(1,9) = .73; p = .681).
For the SAM scale, HLM analysis indicated a time effect in 
all SAM subscales (p< .016) and significant inter-group 
differences for Valence (F(3,48) = 17.40; p< .001), Activation 
(F(3,48) = 8.25; p = .006), and Dominance (F(3,48) = 10.66; p = 
.002) (Figure 3). No significant main effects group x time 
were observed for these variables (p> .30). Univariate 
analyses revealed between-group differences at baseline 
for SAM-Valence (p< .001) and SAM-Dominance (p< .001). 
Between-group scores for SAM-Activation at baseline were 
close to significance (p = .053). A MANOVA analysis of 
recovery found no significant differences in any SAM subscale 
(p = .570).
Discussion
The results only partially support Linehan’s theory (1993). 
As expected, the self-reported variables show that BPD 
individuals have a heightened negative emotional 
intensity at baseline but they do not demonstrate higher 
emotional reactivity to negative stimuli, nor do they 
show a distinct pattern of recovery when compared to 
healthy controls. Apparently, the emotion induction 
procedure that we used was insufficiently specific to 
induce a clear response in endocrine parameters; 
nevertheless, sCORT levels at baseline and throughout 
the procedure suggest an overall altered emotional 
arousal in these patients.
BPD participants displayed lower levels of sCORT at 
baseline and throughout the experiment. Although other 
studies have also reported lower sCORT baseline levels in 
BPD patients (Nater et al., 2010), higher cortisol levels 
have also been described (Lieb et al., 2004). This 
discrepancy could be partially explained by differences in 
methodology and sample characteristics (Wingenfeld, 
Spitzer, Rullkötter, & Löwe, 2010). Furthermore, 
inconsistencies among studies could also rely on the use of 
relatively small samples to study a disorder with a high 
heterogeneity (151 possible combinations resulting from 
the polythetic criteria set for BPD diagnosis). However, the 
higher PSS scores observed in our BPD group suggest a 
relation between diminished cortisol levels at baseline and 
sustained stress, as low cortisol levels have also been 
reported in other populations under long-term stress 
(Fries, Hesse, Hellhammer, & Hellhammer, 2005). It is 
known that most patients with BPD have a life-history of 
traumatic experiences (Leichsenring et al., 2011); this 
persistent exposure to stressors –and also to stress-related 
hormones– could induce changes in the HPAA structures 
thus reducing glucocorticoid release. Additionally, low 
cortisol levels have been found in other patient samples 
that also present behavior problems (Brewer-Smyth, 
Burgués, & Shults, 2004), suggesting that downregulation 
of HPAA could play a role in the behavioral component of 
the disorder.
While no differences in sAA levels were observed at 
baseline, significant between-group differences in sAA 
values during the procedure were found, indicating that 
the BPD group had some degree of  sympathet ic 
overactivation, a finding that is in line with that of other 
authors who have previously described this phenomenon 
in other SNS-related variables (e.g. Ebner-Priemer et al., 
2005; Limberg et al., 2011). To our knowledge, only Nater 
et al. (2010) have examined sAA levels in patients with 
BPD; interestingly, they found –in contrast with our 
results– some evidence of SNS hyporreactivity in the BPD 
group. However, higher overall levels of sAA have been 
reported in a sample of young women with high self-
reported shame and depression (Rohleder, Chen, Wolf, & 
Miller, 2008), both symptoms usually present in BPD 
(Gratz, Rosenthal, Tull, Lejuez, & Gunderson, 2010). 
Remarkably, in the present study an asymmetry between 
sCORT and sAA levels were observed in the BPD group 
compared to HC. Ali and Pruessner (2012) have recently 
reported a similar physiological pattern associated with 
anxiety, social stress and depressive symptomatology in a 
sample of participants exposed to early life adversities. 
Since HPAA and SNS seem interact in a complementary 
way to return the organism to homeostasis (Bauer, Quas, 
& Boyce, 2002), a persistent asymmetry between sCORT 
and sAA levels could indicate dysregulation of the stress 
response.
The data on self-reported measures reveal that mood did 
not worsen faster in BPD patients vs. HC following the 
negative emotional induction, but rather that these patients 
may have a more negative emotional state at baseline. 
Interestingly, scores in self-reported negative emotion 
states have been also positively related to depression and 
anxiety symptomatology (Watson, Clark, & Stasik, 2011), 
symptoms that are commonly present in patients with BPD. 
Similar results have recently been described by other 
authors such as Kuo and Linehan (2009), who found no 
between-group differences in emotional reactivity to 
Baseline Induction1
*
Control
BPD
Induction2 Post-induction
8
6
4
2
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M
-D
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in
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ce
 s
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re
s
*
***
 * p < .05
**p < .001
Figure 3 Mean and SEM values for Self-Assessment-Manikin 
(SAM) subscales (Valence, Activation and Dominance) during the 
procedure. BPD, Borderline Personality Disorder.
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negative film clips or images of a personally-relevant 
condition even though BPD patients had a heightened 
negative emotional intensity at baseline. Self-reported data 
on emotional states described in other stressor induction 
paradigms (Jacob et al., 2009; Staebler, Gebhard, Barnett, 
& Rennenberg, 2009) also support our findings regarding a 
lack of emotional hyperreactivity and heightened basal 
emotional intensity in BPD.
However,  ev idence suggest ing  that  emot ional 
hyperreactivity in BPD should be considered a cue-
dependent feature rather than a trait of this disorder is 
beginning to accumulate. In this regard, Gratz et al. (2010) 
subjected BPD patients to two stressors, one general and 
the other involving negative evaluation (specifically 
designed to induce shame), finding that emotional 
hyperreactivity in BPD was cue-specific and is not present 
in response to a standardized stressor without evaluative 
content. The higher scores in sensitivity to social rejection 
in BPD patients vs. HC reported by Staebler, Helbing, 
Rosenbach, & Renneberg (2011) strengthen the findings 
reported by Gratz et al. (2010) and suggest that further 
emotional induction paradigms should include shame as a 
key emotion to study emotional dysregulation in BPD.
The present study has certain limitations that need to be 
taken into account when evaluating our findings. Primarily, 
the small sample size may have reduced our sensitivity to 
detect differences between groups. In addition, the lack of 
an evident response to emotion-induction in sCORT values 
and the wide dispersion of sAA levels make it difficult 
interpret the results, thus limiting the significance of the 
biological data. Because most BPD patients receive 
pharmacological treatment (Pascua et al., 2010), we elected 
to include these patients in the study in order to increase 
external validity (actually all subjects in the clinical group 
were on psychopharmacological treatment), so the effect of 
medication on biological and self-reported emotional 
response could not be controlled. Future studies will also 
need to use more appropriate interviews to assess possible 
Axis-I comorbidities.
To conclude, the findings presented here do not support 
the hypothesis that BPD patients present greater emotional 
reactivity. However, we did find that BPD patients have 
heightened negative mood intensity at baseline, which we 
believe should be considered a hallmark of the disorder. 
Further studies should incorporate various BPD-specific 
emotional inductions in order to a)determine if emotional 
dysregulation –understood as a stimulus-related feature– 
is actually present in BPD and, if so, b) identify the 
principal emotional cue(s) responsible for triggering this 
dysregulation. Likewise, it seems necessary that any 
future studying include both self-reported variables and 
main biological stress-markers in order to accurately 
describe the processes involved in the emotional 
response.
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